Business
Granting of options over ordinary shares
EDX Medical Group plc has granted options over ordinary shares to directors and senior management, including Deputy Chairman Martin Walton, Chief Financial Officer Shafia Zahoor, Chief Scientific Officer Professor Sir Christopher Evans, Non-Executive Chairman Jason Holt, and Non-Executive Director Professor Trevor Jones. These options were granted under the company's Non-Enterprise Management Incentive Plan and Enterprise Management Incentive Plan, with a total of 9,750,000 options granted to Mr. Walton, 2,267,500 to Ms. Zahoor, 1,500,000 to Professor Sir Christopher Evans, 1,500,000 to Mr. Holt, and 1,500,000 to Professor Trevor Jones, all with a NIL exercise price and dated April 17, 2026. Disclaimer*
About this update from Edx Medical Group Plc
[{"type":"text","content":"\n\n\n \n \n21 April 2026\nEDX Medical Group plc · EDX\nAQSE: EDX\n(\"EDX Medical\" or the \"Company\")\n \nGranting of options over ordinary shares\n \nCAMBRIDGE, UK: EDX Medical Group plc (\"EDX Medical\", the \"Company\" or the \"Group\"), which develops innovative digital diagnostic products and services for the personalised treatment for cancer, heart disease and infectious diseases, today announces that it has granted options over ordinary shares in the Company to directors and other members of senior management. \n \nThe intention to grant options over ordinary shares in the Company was announced to the market on April 13, 2026, as part of the announcement on the proposed application for admission to trading on AIM and proposed withdrawal of the Company's ordinary shares from AQSE. The details of the proposed share options were contained within that announcement. \n \nPrior to the announcement on April 13, 2026, Mr Martin Walton, Deputy Chairman of the Company, already held options over 3,750,000 ordinary shares in the Company. \n \nThe announcement of April 13, 2026, stated the intention for Mr Walton to be granted options over a further 4,214,286 ordinary shares in the Company under the EDX Medical Group plc Non-Enterprise Management Incentive Plan. \n \nThe Board has agreed that Mr Walton's previous option over 3,750,000 ordinary shares in the Company should be cancelled and 're-awarded' under the EDX Medical Group plc Non-Enterprise Management Incentive Plan. This means that Mr Walton now holds options over 7,964,286 ordinary shares in the Company under the EDX Medical Group Plc Non-Enterprise Management Incentive Plan. In addition, Mr Walton holds options over 1,785,714 ordinary shares in the Company under the EDX Medical Group plc Enterprise Management Incentive Plan. Mr Walton's total options over ordinary shares in the Company now stands at 9,750,000. \n \nThe directors of the Company accept responsibility for the contents of this announcement. \n \n\n\n \n \n\n\n\n\n1\n \n\n\nDetails of the person discharging managerial responsibilities / person closely associated\n \n\n\n\n\na)\n \n\n\nName\n \n\n\nMartin Walton\n\n\n\n\n2\n \n\n\nReason ...